National Institutes of Health Grants

235d left D

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Deadline: Oct 14, 2026

$250,000

235d left D

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Deadline: Oct 14, 2026

Not specified

235d left D

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)

Deadline: Oct 14, 2026

Not specified

235d left D

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)

Deadline: Oct 14, 2026

Not specified

235d left D

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)

Deadline: Oct 14, 2026

Not specified

235d left D

Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)

Deadline: Oct 14, 2026

$500,000

235d left D

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Deadline: Oct 14, 2026

Not specified

237d left D

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Deadline: Oct 16, 2026

$300,000

240d left D

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

Deadline: Oct 19, 2026

$50,000

251d left D

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

Deadline: Oct 30, 2026

Not specified

254d left D

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Deadline: Nov 02, 2026

Not specified

254d left D

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

Deadline: Nov 02, 2026

Not specified

257d left D

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Deadline: Nov 05, 2026

Not specified

265d left D

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Deadline: Nov 13, 2026

$350,000

265d left D

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Deadline: Nov 13, 2026

$750,000

265d left D

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Deadline: Nov 13, 2026

$350,000

265d left D

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Deadline: Nov 13, 2026

$1,050,000

268d left D

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

Deadline: Nov 16, 2026

$50,000

269d left D

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

Deadline: Nov 17, 2026

Not specified

269d left D

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Deadline: Nov 17, 2026

Not specified

269d left D

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Deadline: Nov 17, 2026

Not specified

269d left D

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Deadline: Nov 17, 2026

$350,000

270d left D

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

Deadline: Nov 18, 2026

Not specified

270d left D

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

Deadline: Nov 18, 2026

Not specified

271d left D

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Deadline: Nov 19, 2026

Not specified

National Institutes of Health

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)

Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer&apos;s Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)